{"doi":"10.1007/s11912-008-0078-8","title":"Low-grade serous ovarian cancer: a unique disease","abstract":null,"journal":"Current Oncology Reports","year":2008,"id":588748,"datarank":4.548001262742493,"base_score":4.499809670330265,"endowment":4.499809670330265,"self_citation_contribution":0.6749714505495399,"citation_network_contribution":3.8730298121929527,"self_endowment_contribution":0.6749714505495399,"citer_contribution":3.8730298121929527,"corpus_percentile":null,"corpus_rank":null,"citation_count":89,"citer_count":76,"citers_with_citation_signal":66,"citers_with_endowment":66,"datacite_reuse_total":4,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":214920,"name":"David M. Gershenson","orcid":null,"position":1,"is_corresponding":false},{"id":268553,"name":"Kathleen M. Schmeler","orcid":"0000-0002-9670-4189","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Low-grade serous ovarian cancer: a unique disease","abstract":"Low-grade serous carcinomas represent approximately 10% of all serous ovarian carcinomas. A growing body of research has demonstrated several important differences between the clinical and molecular characteristics of these tumors and those of high-grade serous ovarian carcinomas. Patients with low-grade serous ovarian tumors are diagnosed at a younger age, have a longer overall survival, and have lower response rates to conventional chemotherapy. In addition, low-grade serous ovarian carcinomas have pathologic and molecular characteristics distinct from high-grade serous carcinomas, yet similar to serous tumors of low malignant potential. This suggests a common pathogenesis and a continuum of disease from serous tumors of low malignant potential to low-grade serous carcinomas. Further study, focusing specifically on low-grade serous carcinomas, is needed to determine the role of other chemotherapeutic agents, hormonal therapy, or targeted biologic agents in the treatment of this disease.","is_dataset_classified":null,"base_score":4.499809670330265,"endowment":4.499809670330265,"datacite_reuse_total":4,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"18928667","pmcid":null,"openalex_id":"https://openalex.org/W1965859996","authors":[],"funders":[],"total_grants":0,"fwci":4.2274,"citation_percentile":0.92702236,"influential_citations":0,"citation_trend":[{"year":2012,"count":10},{"year":2013,"count":6},{"year":2014,"count":5},{"year":2015,"count":2},{"year":2016,"count":6},{"year":2017,"count":5},{"year":2018,"count":2},{"year":2019,"count":6},{"year":2020,"count":7},{"year":2021,"count":7},{"year":2022,"count":7},{"year":2023,"count":2},{"year":2024,"count":5},{"year":2025,"count":5},{"year":2026,"count":2}],"oa_status":"closed","license":"http://www.springer.com/tdm","oa_locations":[{"url":"http://link.springer.com/content/pdf/10.1007/s11912-008-0078-8.pdf","host_type":"publisher"},{"url":"http://link.springer.com/article/10.1007/s11912-008-0078-8/fulltext.html","host_type":"publisher"},{"url":"http://link.springer.com/content/pdf/10.1007/s11912-008-0078-8","host_type":"publisher"},{"url":"https://doi.org/10.1007/s11912-008-0078-8","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/18928667","host_type":"repository"}],"fields_of_study":["Ovarian cancer diagnosis and treatment","Reproductive Biology and Fertility","PARP inhibition in cancer therapy","Age Factors","Antineoplastic Agents","Cystadenocarcinoma, Serous","Drug Resistance, Neoplasm","Female","Humans","Medical Oncology","Neoadjuvant Therapy","Ovarian Neoplasms","Ovary","Recurrence","Treatment Outcome"],"mesh_terms":["Age Factors","Antineoplastic Agents","Female","Humans","Medical Oncology","Ovarian Neoplasms","Ovary","Recurrence","Treatment Outcome","Cystadenocarcinoma, Serous","Drug Resistance, Neoplasm","Neoadjuvant Therapy"],"keywords":["Serous fluid","Medicine","Serous ovarian cancer","Ovarian carcinomas","Serous carcinoma","Ovarian cancer","Oncology","Pathology","Cystadenocarcinoma","Disease","Internal medicine","Ovarian carcinoma","Cancer"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Zero hunger"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.14903924.v1","title":"Additional file 2 of Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14903924","title":"Additional file 2 of Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14903921","title":"Additional file 1 of Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.14903921.v1","title":"Additional file 1 of Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer","publisher":"figshare","resource_type":"Dataset"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-22T20:11:57.097052Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}